Sr. Clinical Development Physician Lead | Attractive & Fast Growing Cardiovascular Biotech | 1st-in-Class/Late-Stage Franchise | Rare Oppty Make Lasting Imprints

Sr. Clinical Development Physician Lead | Attractive & Fast Growing Cardiovascular Biotech | 1st-in-Class/Late-Stage Franchise | Rare Oppty Make Lasting Imprints

Our client is a highly attractive and rapidly growing clinical-stage biotechnology company that is redefining the future of cardiovascular medicine. With a differentiated pipeline of precision cardiovascular therapies—including multiple potentially transformative late-stage, first-in-class programs—and supported by a strong financial foundation and a proven executive leadership team with an outstanding track record in this space, the organization is building what many believe will become a leading precision cardiovascular franchise and a new modernized model for cardiovascular drug development innovation.

As the company enters a pivotal phase of growth and expansion, they are seeking an experienced clinical development physician to help advance their 1st-in-class cardiovascular franchise and lead the clinical development, strategy and execution for one of its flagship late-stage programs. For clinical development physicians who are energized by solving complex scientific challenges, translating breakthrough science into transformative medicines, driving innovation, this represents an exceptional career opportunity to make a lasting imprint on a next-generation approach to how cardiovascular medicines are developed.

You will join a collaborative team that values scientific rigor, entrepreneurial thinking, and bold innovation. You'll have the opportunity to influence clinical development for a flagship late-stage program, work on cutting-edge science alongside respected leaders in cardiovascular medicine, and help shape the future of a company committed to transforming how cardiovascular disease is treated.

ATTRACTIVE FEATURES ABOUT THIS COMPANY & OPPORTUNITY:

• Lasting Impact : A unique opportunity to influence clinical development, work on cutting-edge science, bring meaningful/transformative cardiovascular therapies to patients, and your work here will directly influence the future direction of both the program and organization.
• Help Shape the Future of Cardiovascular Drug Development: By combining a broad portfolio of innovative 1st-in-class therapeutics with AI-enabled clinical development, precision trial design, an industry-leading cardiac intelligence platform, this company is creating a new modernized model for cardiovascular drug development and innovation.
• Strategy & Execution for 1st-in-Class/Late-Stage Cardiovascular Program: You will help lead end-to-end development for one of the company’s highest-priority and strategically important programs for underserved cardiovascular populations.
• Build Rather Than Maintain : Join a company aiming to build a broad CV franchise in disease areas where there are no approved products. In this role, you'll help bring transformative therapies to patients with significant unmet medical needs, and your work here will help create medicines that have the potential to redefine treatment for patients.
• Well-Funded Biotech with Long-Term Vision: Supported by a strong financial foundation, an expanding/differentiated pipeline, and a proven executive leadership team, the company offers the resources to execute ambitious clinical programs while maintaining the agility, speed, and entrepreneurial culture of an innovative biotechnology company that is built to change the standard of care.
• Highly Accomplished & Proven Leadership: Work with an accomplished Executive Leadership team with a proven track record of developing innovative medicines, advancing successful cardiovascular programs, and building high-performing biotech organizations.

RESPONSIBILITIES IN A NUTSHELL:

• Lead the clinical strategy, planning and execution for key aspects of a high-value cardiovascular clinical development program.
• Provide clinical/scientific input into the development, design, delivery, and communication of the global evidence generation plan.
• Support cross-functional and global collaborations to integrate broad medical, scientific, and commercial input into the development program.
• Help define the scientific narrative for a novel cardiovascular asset.
• Leads the clinical strategic planning, authoring and review of clinical parts of regulatory submissions and scientific data disclosures of the studies.
• Partner with cross-functional teams to analyze, interpret, and communicate clinical trial data and results.
• Lead the design, authoring, and oversight of clinical protocols, amendments, study reports, and related development documents.
• Provides oversight with the operational aspects of study conduct including site selection and activation, site investigator and staff training, budget planning and contract review.
• Will make scientific presentation at advisory boards, key scientific meetings and external committee meetings.
• Guide interactions with investigators, clinical experts, and global opinion leaders to strengthen program design and execution.

DESIRED EXPERIENCE:

• Medical Degree (M.D.) is required. Board Certification is preferred.
• Minimum 5+ years of relevant cardiovascular clinical drug development experience working in the pharmaceutical/biotech industry.
• Experience designing and running late-stage development cardiovascular trials (Phase 2b/3), ideally from pre-IND to NDA submission.
• Proven ability to interpret complex clinical data and translate findings into development strategy.
• Proven ability to work effectively in a fast-paced, startup/entrepreneurial type of environment, to be self-motivated, and to communicate effectively with leadership on-site and internally.

CONTACT:

Brian Skurka, Partner

View email address on click.appcast.io – P View phone number on click.appcast.io

LinkedIn:

Cornerstone Search Group, LLC

1200 Morris Tpke, Suite 3005 | Short Hills, New Jersey (USA)

RECENTLY COMPLETED RETAINED SEARCHES BY CORNERSTONE:

• Chief Medical Officer | Clinical-stage biotech
• Chief Scientific Officer | Mid-size global biotech
• VP, Oncology Drug Development | Early/later-stage oncology biotech
• Head of HR/Talent Acquisition | Clinical-stage immunology biotech
• VP, Clinical Operations | Early-stage biotech startup
• VP & Head, Program Management| Clinical-stage rare disease biotech
• VP, Clinical Operations | MA-based mid-size biotech
• ED, Clinical R&D, Oncology | Early-stage I-O biotech
• ED, Early Development, I-O | Top 10 Onc/I-O biopharma
• VP/Head of Manufacturing| Clinical-stage neuroscience biotech
• Sr. Medical Director, Clinical Development Oncology

About CORNERSTONE SEARCH GROUP

Cornerstone is recognized by Forbes as one of the "Top 100 Executive Search Firms in the U.S." (and the only Top 100 firm to focus exclusively in the Life Sciences Industry), and by Hunt Scanlon as one of the "Top 50 Healthcare & Life Sciences Executive Search Firms" , is a Life Sciences Executive Search firm that helps companies based around the world, ranging from startup biotechs to Top 10 Pharmas, to find, attract, and hire talent for their US and globally-based leadership positions (CxO and xVP levels) as well as their critical Director-level roles.

Cornerstone’s Privacy Policy: Cornerstone Search Group considers all inquiries, resume submissions, and any other personal information submitted to us as confidential information. This information will not be shared with any parties outside of Cornerstone Search Group without your prior permission.